Cardinal Health Falls to 437th in Trading Volume Amid 57.9% Institutional Stake Increase and Bullish Analyst Upgrades

Cardinal Health (CAH) declined 1.04% on August 6, 2025, with a trading volume of $270 million, a 26.63% drop from the previous day, ranking it 437th in volume among listed stocks. Institutional investors have increased stakes in the company, with New Age Alpha Advisors LLC boosting its holdings by 57.9% in the first quarter to 95,934 shares, valued at $13.2 million. The firm now holds CAH as its 21st largest position, comprising 0.6% of its portfolio. Meanwhile, brokerages including Citigroup and UBS Group raised price targets to $170 and $160, respectively, signaling a bullish outlook amid strategic upgrades.

Analyst sentiment remains positive, with 12 “buy” ratings and three “hold” ratings currently assigned to CAH. Recent upgrades include Evercore ISI’s $180 price target and Morgan Stanley’s elevated $190 target, reflecting confidence in the company’s ability to capitalize on rising acute care demand. Institutional ownership now accounts for 87.17% of the stock, with notable additions from Tompkins Financial Corp and Itau Unibanco in the fourth quarter. These developments underscore growing investor confidence in Cardinal Health’s market positioning despite its recent price decline.

The strategy of purchasing the top 500 stocks by daily trading volume and holding them for one day delivered a 166.71% return from 2022 to the present, outperforming the benchmark return of 29.18% by 137.53%. This underscores the role of liquidity concentration in short-term stock performance, particularly in volatile markets.